Edition:
United States

InVivo Therapeutics Holdings Corp (NVIV.OQ)

NVIV.OQ on NASDAQ Stock Exchange Capital Market

2.08USD
4:00pm EDT
Change (% chg)

$0.03 (+1.46%)
Prev Close
$2.05
Open
$2.10
Day's High
$2.19
Day's Low
$2.07
Volume
72,814
Avg. Vol
61,077
52-wk High
$37.50
52-wk Low
$1.64

Chart for

About

InVivo Therapeutics Holdings Corp., formerly Design Source, Inc., is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company's approach to treating acute SCIs is based... (more)

Overall

Beta: 2.26
Market Cap(Mil.): $15.76
Shares Outstanding(Mil.): 7.76
Dividend: --
Yield (%): --

Financials

  NVIV.OQ Industry Sector
P/E (TTM): -- 47.38 32.14
EPS (TTM): -101.34 -- --
ROI: -355.64 8.41 12.83
ROE: -372.06 11.97 14.95

BRIEF-Invivo Therapeutics Reports Q1 Loss Per Share Of $3.34

* INVIVO THERAPEUTICS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS

May 07 2018

BRIEF-Invivo Therapeutics Files For Offering Of Up To $8 Mln Shares

* INVIVO THERAPEUTICS HOLDINGS CORP FILES FOR OFFERING OF UP TO $8 MILLION SHARES OF COMMON STOCK, WARRANTS TO PURCHASE SHARES OF COMMON STOCK - SEC FILING Source text (https://bit.ly/2HrYEIM) Further company coverage:

Apr 24 2018

Earnings vs. Estimates